Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066817

Chief Scientific Officer gave up 836 shares (to pay taxes)

  • Chief Scientific Officer acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shanler Stuart · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-15 Exercise or conversion : show line 1 in the form +1,300 263,178 D
2017-12-15 Shares withheld for taxes : show line 2 in the form −395 $24.23 $9,571 262,783 D
2017-12-18 Exercise or conversion : show line 3 in the form +1,450 264,233 D
2017-12-18 Shares withheld for taxes : show line 4 in the form −441 $24.12 $10,637 263,792 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-12-15 Exercise or conversion : show line 5 in the form Restricted Stock Units −1,300 9,100 D
2017-12-18 Exercise or conversion : show line 6 in the form Restricted Stock Units −1,450 2,900 D
Loading xslF345X03/doc4.xml…